Indefinite Delivery Contract SPE2DU25D2117

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $4,999,999.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an ultimate completion date of December 31, 2036, aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet.

The contract covers an extensive array of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. The contract is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. This acquisition will be a Lowest Price Technically Acceptable (LPTA) award, with the potential use of a reverse auction strategy to obtain the best distribution fees.